Divalent cations modulate α2β1 integrin-mediated malignancy in a novel 3-dimensional in vitro model of pancreatic cancer

Pancreas

Volumn 39, Issue 6, 2010, Pages 904-912

  Grzesiak, John J ^a   Vargas, Fabian ^a   Bouvet, Michael ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

cell adhesion; cell proliferation; pancreatic adenocarcinoma; type I collagen

Indexed keywords

BETA CATENIN; CALCIUM ION; COLLAGEN TYPE 1; DIVALENT CATION; MAGNESIUM ION; UVOMORULIN; VERY LATE ACTIVATION ANTIGEN 2;

ARTICLE; CANCER CELL; CELL ADHESION; CELL INTERACTION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); IMMUNOBLOTTING; IN VITRO STUDY; MICROSCOPY; MODULATION; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; THREE DIMENSIONAL IMAGING; TUMOR MICROENVIRONMENT;

BETA CATENIN; CADHERINS; CALCIUM; CATIONS, DIVALENT; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOBLOTTING; INTEGRIN ALPHA2BETA1; MAGNESIUM; PANCREATIC NEOPLASMS;

EID: 77955194419     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181ce60a3     Document Type: Article

References (62)

1. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol. 1990;8:365Y400.
2. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673Y687.
3. Ruoslahti E. Integrins. J Clin Invest. 1991;87:1Y5.
4. Ruoslahti E, Noble NA, Kagami S, et al. Integrins. Kidney Int Suppl. 1994;44:S17YS22.
5. Springer TA. Adhesion receptors of the immune system. Nature. 1990;346:425Y434.
6. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science. 1987;238:491Y497.
7. Dransfield I, Hogg N. Regulated expression of Mg2+ binding epitope on leukocyte integrin alpha subunits. EMBO J. 1989;8:3759Y3765.
8. Fitzgerald LA, Phillips DR. Calcium regulation of the platelet membrane glycoprotein IIb-IIIa complex. J Biol Chem. 1985;260: 11366Y11374.
9. Fujimura K, Phillips DR. Calcium cation regulation of glycoprotein IIb-IIIa complex formation in platelet plasma membranes. J Biol Chem. 1983;258:10247Y10252.
10. Hynes RO. Targeted mutations in cell adhesion genes: what have we learned from them? Dev Biol. 1996;180:402Y412.
11. Kirchhofer D, Grzesiak J, Pierschbacher MD. Calcium as a potential physiological regulator of integrin-mediated cell adhesion. J Biol Chem. 1991;266:4471Y4477.
12. Argraves WS, Suzuki S, Arai H, et al. Amino acid sequence of the human fibronectin receptor. J Cell Biol. 1987;105:1183Y1190.
13. Loftus JC, O'Toole TE, Plow EF, et al. A beta 3 integrin mutation abolishes ligand binding and alters divalent cationYdependent conformation. Science. 1990;249:915Y918.
14. Binkley CE, Zhang L, Greenson JK, et al. The molecular basis of pancreatic fibrosis: common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma. Pancreas. 2004; 29:254Y263.
15. Linder S, Castanos-Velez E, von Rosen A, et al. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma. Hepatogastroenterology. 2001;48:1321Y1327.
16. Mollenhauer J, Roether I, Kern HF. Distribution of extracellular matrix proteins in pancreatic ductal adenocarcinoma and its influence on tumor cell proliferation in vitro. Pancreas. 1987;2:14Y24.
17. Stein WD, Litman T, Fojo T, et al. A serial analysis of gene expression (SAGE) database analysis of chemosensitivity: comparing solid tumors with cell lines and comparing solid tumors from different tissue origins. Cancer Res. 2004;64:2805Y2816.
18. Grzesiak JJ, Ho JC, Moossa AR, et al. The integrinYextracellular matrix axis in pancreatic cancer. Pancreas. 2007;35:293Y301.
19. Armstrong T, Packham G, Murphy LB, et al. Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2004;10:7427Y7437.
20. Bachem MG, Schunemann M, Ramadani M, et al. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology. 2005;128:907Y921.
21. Grzesiak JJ, Bouvet M. The >2A1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines. Br J Cancer. 2006;94:1311Y1319.
22. Grzesiak JJ, Smith KC, Chalberg C, et al. Type I collagen and divalent cation shifts disrupt cell-cell adhesion, increase migration, and decrease PTHrP, IL-6, and IL-8 expression in pancreatic cancer cells. Int J Gastrointest Cancer. 2005;36:131Y146.
23. Imamichi Y, Konig A, Gress T, et al. Collagen type IYinduced Smad-interacting protein 1 expression downregulates E-cadherin in pancreatic cancer. Oncogene. 2007;26:2381Y2385.
24. Koenig A, Mueller C, Hasel C, et al. Collagen type I induces disruption of E-cadherinYmediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. Cancer Res. 2006; 66:4662Y4671.
25. Shintani Y, Hollingsworth MA, Wheelock MJ, et al. Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH2-terminal kinase 1 and up-regulating N-cadherin expression. Cancer Res. 2006;66:11745Y11753.
26. Grzesiak JJ, Bouvet M. Determination of the ligand binding specificities of the >2A1 and >1A1 integrins in a novel three-dimensional in vitro model of pancreatic cancer. Pancreas. 2007;34:220Y228.
27. Grzesiak JJ, Bouvet M. Activation of the >2A1 integrinYmediated malignant phenotype on type I collagen in pancreatic cancer cells by shifts in the concentrations of extracellular Mg2+ and Ca2+. Int J Cancer. 2008;122:2199Y2209.
28. Grzesiak JJ, Bouvet M. Divalent cations modulate the integrin-mediated malignant phenotype in pancreatic cancer cells. Cancer Sci. 2008; 99:1553Y1563.
29. Grzesiak JJ, Davis GE, Kirchhofer D, et al. Regulation of alpha 2 beta 1Ymediated fibroblast migration on type I collagen by shifts in the concentrations of extracellular Mg2+ and Ca2+. J Cell Biol. 1992; 117:1109Y1117.
30. Grzesiak JJ, Pierschbacher MD. Changes in the concentrations of extracellular Mg++ and Ca++ down-regulate E-cadherin and up-regulate alpha 2 beta 1 integrin function, activating keratinocyte migration on type I collagen. J Invest Dermatol. 1995;104:768Y774.
31. Grzesiak JJ, Pierschbacher MD. Shifts in the concentrations of magnesium and calcium in early porcine and rat wound fluids activate the cell migratory response. J Clin Invest. 1995;95:227Y233.
32. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer. 2002;2:897Y909.
33. Menke A, Adler G. TGFbeta-induced fibrogenesis of the pancreas. Int J Gastrointest Cancer. 2002;31:41Y46.
34. Ishihara N, Yoshida A, Koizumi M. Metal concentrations in human pancreatic juice. Arch Environ Health. 1987;42:356Y360.
35. Shimoyama S, Gansauge F, Gansauge S, et al. Altered expression of extracellular matrix molecules and their receptors in chronic pancreatitis and pancreatic adenocarcinoma in comparison with normal pancreas. Int J Pancreatol. 1995;18:227Y234.
36. Cunningham JJ, Anbar RD, Crawford JD. Hypomagnesemia: a multifactorial complication of treatment of patients with severe burn trauma. JPEN J Parenter Enteral Nutr. 1987;11:364Y367.
37. Durlach J. Magnesium and its relationship to oncology. In: Sigel H, Sigel A, eds. Metal Ions in Biological Systems. New York, NY: Marcel Dekker, Inc, 1990:549Y578.
38. Durlach J, Bara M, Guiet-Bara A, et al. Relationship between magnesium, cancer and carcinogenic or anticancer metals. Anticancer Res. 1986;6:1353Y1361.
39. Grzesiak JJ, Clopton P, Chalberg C, et al. The extracellular matrix differentially regulates the expression of PTHrP and the PTH/PTHrP receptor in FG pancreatic cancer cells. Pancreas. 2004;29:85Y92.
40. Dagalakis N, Flink J, Stasikelis P, et al. Design of an artificial skin. Part III. Control of pore structure. J Biomed Mater Res. 1980;14:511Y528.
41. Yannas IV, Burke JF. Design of an artificial skin. I. Basic design principles. J Biomed Mater Res. 1980;14:65Y81.
42. Yannas IV, Burke JF, Gordon PL, et al. Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res. 1980; 14:107Y132.
43. Yannas IV, Lee E, Orgill DP, et al. Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. Proc Natl Acad Sci U S A. 1989;86:933Y937.
44. Masuda H, Ozeki T, Takazono I, et al. Composition of glycosaminoglycans in human pancreatic cancer. Biochem Med Metab Biol. 1989;41:193Y200.
45. Theocharis AD, Tsara ME, Papageorgacopoulou N, et al. Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition. Biochim Biophys Acta. 2000;1502:201Y206.
46. Grzesiak JJ, Pierschbacher MD, Amodeo MF, et al. Enhancement of cell interactions with collagen/glycosaminoglycan matrices by RGD derivatization. Biomaterials. 1997;18:1625Y1632.
47. Wayner EA, Carter WG. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits. J Cell Biol. 1987;105:1873Y1884.
48. Wayner EA, Carter WG, Piotrowicz RS, et al. The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J Cell Biol. 1988;107:1881Y1891.
49. Wayner EA, Gil SG, Murphy GF, et al. Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for alpha 3 beta 1 positive T lymphocytes. J Cell Biol. 1993;121:1141Y1152.
50. Grzesiak JJ, Smith KC, Burton DW, et al. GSK3 and PKB/Akt are associated with integrin-mediated regulation of PTHrP, IL-6 and IL-8 expression in FG pancreatic cancer cells. Int J Cancer. 2005; 114:522Y530.
51. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991;251:1451Y1455.
52. Wong NA, Pignatelli M. Beta-cateninVa linchpin in colorectal carcinogenesis? Am J Pathol. 2002;160:389Y401.
53. Iacobuzio-Donahue CA, Ashfaq R, Maitra A, et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res. 2003;63:8614Y8622.
54. Iacobuzio-Donahue CA, Maitra A, Olsen M, et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol. 2003;162:1151Y1162.
55. Thamilselvan V, Fomby M, Walsh M, et al. Divalent cations modulate human colon cancer cell adhesion. J Surg Res. 2003;110:255Y265.
56. van der Voort van Zyp J, Conway WC, Thamilselvan V, et al. Divalent cations influence colon cancer cell adhesion in a murine transplantable tumor model. Am J Surg. 2005;190:701Y707.
57. Nakao A, Fujii T, Sugimoto H, et al. Oncological problems in pancreatic cancer surgery. World J Gastroenterol. 2006;12:4466Y4472.
58. van Grevenstein WM, Hofland LJ, Jeekel J, et al. The expression of adhesion molecules and the influence of inflammatory cytokines on the adhesion of human pancreatic carcinoma cells to mesothelial monolayers. Pancreas. 2006;32:396Y402.
59. Bouvet M, Spernyak J, Katz MH, et al. High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer. Cancer Res. 2005;65: 9829Y9833.
60. Bouvet M, Wang J, Nardin SR, et al. Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res. 2002;62:1534Y1540.
61. Katz MH, Takimoto S, Spivack D, et al. A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J Surg Res. 2003;113:151Y160. (Pubitemid 36999806)
62. Katz MH, Takimoto S, Spivack D, et al. An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer. Clin Exp Metastasis. 2004;21:7Y12.